The CRA is responsible for the initiation, monitoring and closure of assigned sites in clinical studies, in compliance with sponsor's procedural documents, international guidelines such as ICH-GCP, and relevant local regulations. They ensure the sites deliver according to their respective commitment in the individual studies and act as a primary point of contact between site staff and the sponsor.